Provided by Tiger Fintech (Singapore) Pte. Ltd.

NovaBay Pharmaceuticals

0.6300
-0.0145-2.25%
Volume:75.87K
Turnover:47.28K
Market Cap:3.08M
PE:-0.06
High:0.6500
Open:0.6500
Low:0.6112
Close:0.6445
Loading ...

BRIEF-Novabay Pharmaceuticals Engages Financial Advisor Should Stockholders Fail To Approve Dissolution Proposal

Reuters
·
07 Mar

NovaBay Pharmaceuticals Inc: Stockholders as of March 18, 2025 Record Date Will Be Entitled to Vote

THOMSON REUTERS
·
07 Mar

NovaBay Pharmaceuticals Inc: Engages Financial Advisor to Explore Strategic Options Should Stockholders Fail to Approve Dissolution Proposal

THOMSON REUTERS
·
07 Mar

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders

Business Wire
·
07 Mar

BRIEF-Novabay Pharmaceuticals Completes The Sale Of Its Eyecare Business To Prn

Reuters
·
23 Jan

NovaBay Pharmaceuticals Completes the Sale of Its Eyecare Business to Prn and Further Adjourns Its Special Meeting of Stockholders on Dissolution Proposal

THOMSON REUTERS
·
23 Jan

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal

Business Wire
·
23 Jan

NovaBay Pharmaceuticals (NBY) Upgraded to Buy: Here's Why

Zacks
·
26 Dec 2024

ISS supports NovaBay proposals to sell Avenova business

TIPRANKS
·
15 Nov 2024

BRIEF-NovaBay Pharmaceuticals ISS Supports Co's Proposals To Authorize Sale Of Its Avenova Brand

Reuters
·
15 Nov 2024

NovaBay Pharmaceuticals: Iss Supports Co's Proposals to Authorize Sale of Its Avenova Brand

THOMSON REUTERS
·
15 Nov 2024

NovaBay Pharmaceuticals Reports Q3 2024 Financials Amid Strategic Changes

TIPRANKS
·
15 Nov 2024

NovaBay Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
12 Nov 2024

NovaBay Pharmaceuticals Q3 EPS $(0.60) Misses $(0.30) Estimate, Sales $2.44M Miss $2.62M Estimate

Benzinga
·
08 Nov 2024

NovaBay Pharmaceuticals Inc: Qtrly Shr Loss $0.60

THOMSON REUTERS
·
08 Nov 2024

BRIEF-Novabay Pharmaceuticals accepts revised offer from Nutriceuticals

Reuters
·
07 Nov 2024